National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 11248-11249 [05-4487]

Download as PDF 11248 Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Health Professions Preparatory, Health Professions Pregraduate and Indian Health Professions Scholarship Programs; Correction ACTION: Notice; correction. SUMMARY: The Indian Health Service published a document in the Federal Register on January 19, 2005. The document contained one error. FOR FURTHER INFORMATION CONTACT: Mr. Jess Brien, Chief, Scholarship Branch, Indian Health Service, 801 Thompson Avenue, Suite 120, Rockville, Maryland 20852; telephone 301–443–6197. (This is not a toll-free number.) Correction In the Federal Register of January 19, 2005, in FR Doc. 05–1030, on page 3046, in the second column, correct the Application Review Date to read April 18–April 22, 2005. Dated: February 28, 2005. Robert G. McSwain, Deputy Director, Indian Health Service. [FR Doc. 05–4479 Filed 3–7–05; 8:45 am] Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Mary C. Fletcher, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Rm 8115, Bethesda, MD 20892, (301) 496–7413. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS.) Dated: March 1, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–4498 Filed 3–7–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–16–M National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee E—Cancer Epidemiology, Prevention & Control. Date: April 6–8, 2005. Time: 7 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. VerDate jul<14>2003 19:54 Mar 07, 2005 Jkt 205001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Sepsis and CAP: Partnerships for Diagnostics Development. Date: March 21–22, 2005. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Stefani T. Rudnick, PhD, Scientific Review Administrator, Scientific PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–496–2550, srudnick@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Hepatitis C Cooeprative Research Centers. Date: March 23–25, 2005. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–435– 2766, gm145a@nih.gov. Name of Committee: National Institutes of Allergy and Infectious Diseases Special Emphasis Panel Novel HIV Therapeutics: Integrated Preclinical/Clinical Program (IPCP). Date: March 23–25, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Tracy A. Shahan, PhD, Scientific Review Adminsitrator, Scientific Review Program, Divison of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, 301–496–2606, tshahan@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Disorders of Therapeutic Immunosuppression. Date: March 23, 2005. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, 3147, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Duane Price, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 2217, 6700B, Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2550; dprice@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Emphasis Panel ‘‘Animal Models for the Prevention and Treatment of Hepatitis B and Hepatitis C.’’ Date: March 24, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Lucy A. Ward, DVM, Scientific Review Administrator, Scientific Review Program, Division of Extramual Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, Room 3117, Bethesda, MD 20892–7616, (301) 496–2550; lw275a@nih.gov. E:\FR\FM\08MRN1.SGM 08MRN1 Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel IPCP. Date: March 31, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Tracy A. Shahan, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramual Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2606; tshahan@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS.) (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS.) Dated: March 1, 2005. Anna P. Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–4487 Filed 3–7–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M Pursuant to section 10(d) of the Federal Advisory Committee, Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel Trauma and Burn Research Center Program. Date: March 29, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Brian R. Pike PhD, Scientific Review Administrator, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18, Bethesda, MD 20892, (301) 594–3907, pikbr@mail.nih.gov. VerDate jul<14>2003 19:54 Mar 07, 2005 Jkt 205001 Dated: March 1, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–4489 Filed 3–7–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel Exploratory Center Grants for hESC Research. Date: March 29–30, 2005. Time: 9 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Rebecca H. Johnson, PhD, Scientific Review Administrator, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18C, Bethesda, MD 20892, 301–594–2771, johnsonrh@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS.) PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 11249 Dated: March 1, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–4490 Filed 3–7–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group Acquired Immunodeficiency Syndrome Research Review Committee, AIDS Research Review Committee. Date: March 23–24, 2005. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814. Contact Person: Roberta Binder, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3130, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–7966, rb169n@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS.) Dated: March 1, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–4491 Filed 3–7–05; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 70, Number 44 (Tuesday, March 8, 2005)]
[Notices]
[Pages 11248-11249]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4487]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Sepsis and CAP: Partnerships for 
Diagnostics Development.
    Date: March 21-22, 2005.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Stefani T. Rudnick, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-496-2550, 
srudnick@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Hepatitis C Cooeprative Research 
Centers.
    Date: March 23-25, 2005.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., 
Washington, DC 20007.
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-435-2766, 
gm145a@nih.gov.

    Name of Committee: National Institutes of Allergy and Infectious 
Diseases Special Emphasis Panel Novel HIV Therapeutics: Integrated 
Preclinical/Clinical Program (IPCP).
    Date: March 23-25, 2005.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver 
Spring, MD 20910.
    Contact Person: Tracy A. Shahan, PhD, Scientific Review 
Adminsitrator, Scientific Review Program, Divison of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, 301-496-2606, tshahan@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Disorders of Therapeutic 
Immunosuppression.
    Date: March 23, 2005.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, 3147, Bethesda, MD 20817, (Telephone Conference 
Call).
    Contact Person: Duane Price, PhD, Scientific Review 
Administrator, NIAID, DEA, Scientific Review Program, Room 2217, 
6700B, Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 
496-2550; dprice@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Emphasis Panel ``Animal Models for the Prevention and 
Treatment of Hepatitis B and Hepatitis C.''
    Date: March 24, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Lucy A. Ward, DVM, Scientific Review 
Administrator, Scientific Review Program, Division of Extramual 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, Room 3117, Bethesda, MD 20892-7616, (301) 496-2550; 
lw275a@nih.gov.


[[Page 11249]]


    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel IPCP.
    Date: March 31, 2005.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Tracy A. Shahan, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramual 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 496-2606; 
tshahan@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS.)

    Dated: March 1, 2005.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-4487 Filed 3-7-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.